PSM101
EGFR‑overexpressing solid tumors
PreclinicalActive
Key Facts
About PrecisemAb Biotech
A Taiwan biotech delivering safer, tumor‑selective antibodies via a protease‑activated lock technology.
View full company profileEGFR‑overexpressing solid tumors
A Taiwan biotech delivering safer, tumor‑selective antibodies via a protease‑activated lock technology.
View full company profile